WALTHAM, Mass.--(BUSINESS WIRE)--Inverness Medical Innovations, Inc. (Amex: IMA), today announced that Biosite(R) Incorporated (Nasdaq: BSTE) has failed to respond to Inverness’ proposal to acquire the company in a cash merger transaction for $90.00 per share. The proposal was delivered to Biosite’s Board in a letter dated April 4th.
